The Scientific and Clinical Team at Ablacon focuses on advancing and validating the EGF™ mapping capabilities of Ablamap®. They work on designing and overseeing clinical trials, analyzing scientific data, and providing expert consultation to improve understanding and treatment of atrial fibrillation through innovative machine intelligence systems.